Die Aortenklappeninsuffizienz – können wir mit interventionellen Therapieoptionen mehr Patienten helfen?

Matti Adam; Eberhard Grube

doi:10.1055/a-1922-6387

Aktuelle Kardiologie, Table of Contents

Aktuelle Kardiologie 2022; 11(05): 444-449
DOI: 10.1055/a-1922-6387

Kurzübersicht

Die Aortenklappeninsuffizienz – können wir mit interventionellen Therapieoptionen mehr Patienten helfen?

Aortic Valve Regurgitation – Can We Help More Patients with Interventional Therapy Options?

Matti Adam

¹Klinik III für Innere Medizin - Kardiologie, Pneumologie und internistische Intensivmedizin, Klinikum der Universität zu Köln Herzzentrum, Köln, Deutschland (Ringgold ID: RIN234273)

,

Eberhard Grube

²Herzzenturm, Universitätsklinikum Bonn, Bonn, Deutschland (Ringgold ID: RIN39062)

› Author Affiliations

Abstract

Zusammenfassung

Die hochgradige, symptomatische Aortenklappeninsuffizienz ist häufig nicht einfach zu diagnostizieren und bei einem relevanten Anteil der Patienten noch nicht ausreichend gut behandelt. Dabei können auch Patienten mit höherem operativen Risiko von einem Aortenklappenersatz profitieren. Durch das Fortschreiten der interventionellen Therapieoptionen stellt die Transkatheter-Aortenklappenimplantation (TAVI) mittlerweile eine ebenfalls zu berücksichtigende Therapieoption dar. Dadurch kann es möglich werden, auch ältere und kränkere Patienten einer adäquaten und notwendigen Therapie der Aortenklappeninsuffizienz zuzuführen.

Abstract

Severe symptomatic aortic valve regurgitation is often not easy to diagnose and in a relevant proportion of patients it is not yet sufficiently well treated. In this context, patients at higher surgical risk may also benefit from aortic valve replacement. With the advancement of interventional therapy options, transcatheter aortic valve implantation (TAVI) is now a therapeutic option that should also be considered. This may make it possible to provide older and sicker patients with adequate and necessary therapy for aortic valve insufficiency.

Schlüsselwörter

Aortenklappeninsuffizienz - TAVI - Aortenklappenersatz

Keywords

aortic regurgitation - TAVR - aortic valve replacement

Full Text

References

Literatur
1 Iung B, Baron G, Butchart EG. et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003; 24: 1231-1243
2 Nkomo VT, Gardin JM, Skelton TN. et al. Burden of valvular heart diseases: a population-based study. Lancet 2006; 368: 1005-1011
3 Singh JP, Evans JC, Levy D. et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol 1999; 83: 897-902
4 Roberts WC, Ko JM, Moore TR. et al. Causes of pure aortic regurgitation in patients having isolated aortic valve replacement at a single US tertiary hospital (1993 to 2005). Circulation 2006; 114: 422-429
5 Bonow RO. Chronic mitral regurgitation and aortic regurgitation: have indications for surgery changed?. J Am Coll Cardiol 2013; 61: 693-701
6 Dujardin KS, Enriquez-Sarano M, Schaff HV. et al. Mortality and morbidity of aortic regurgitation in clinical practice. A long-term follow-up study. Circulation 1999; 99: 1851-1857
7 Evangelista A, Tornos P, Sambola A. et al. Long-term vasodilator therapy in patients with severe aortic regurgitation. N Engl J Med 2005; 353: 1342-1349
8 Broch K, Urheim S, Lønnebakken MT. et al. Controlled release metoprolol for aortic regurgitation: a randomised clinical trial. Heart 2016; 102: 191-197
9 Vahanian A, Beyersdorf F, Praz F. et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2022; 43: 561-632
10 Thourani VH, Brennan JM, Edelman JJ. et al. Treatment Patterns, Disparities, and Management Strategies Impact Clinical Outcomes in Patients with Symptomatic Severe Aortic Regurgitation. Structural Heart 2021; 5: 608-618
11 Roy DA, Schaefer U, Guetta V. et al. Transcatheter aortic valve implantation for pure severe native aortic valve regurgitation. J Am Coll Cardiol 2013; 61: 1577-1584
12 Testa L, Latib A, Rossi ML. et al. CoreValve implantation for severe aortic regurgitation: a multicentre registry. EuroIntervention 2014; 10: 739-745
13 Anwaruddin S, Desai ND, Szeto WY. et al. Self-Expanding Valve System for Treatment of Native Aortic Regurgitation by Transcatheter Aortic Valve Implantation (from the STS/ACC TVT Registry). Am J Cardiol 2019; 124: 781-788
14 Yoon SH, Schmidt T, Bleiziffer S. et al. Transcatheter Aortic Valve Replacement in Pure Native Aortic Valve Regurgitation. J Am Coll Cardiol 2017; 70: 2752-2763
15 Sawaya FJ, Deutsch MA, Seiffert M. et al. Safety and Efficacy of Transcatheter Aortic Valve Replacement in the Treatment of Pure Aortic Regurgitation in Native Valves and Failing Surgical Bioprostheses: Results From an International Registry Study. JACC Cardiovasc Interv 2017; 10: 1048-1056
16 De Backer O, Pilgrim T, Simonato M. et al. Usefulness of Transcatheter Aortic Valve Implantation for Treatment of Pure Native Aortic Valve Regurgitation. Am J Cardiol 2018; 122: 1028-1035
17 Silaschi M, Conradi L, Wendler O. et al. The JUPITER registry: One-year outcomes of transapical aortic valve implantation using a second generation transcatheter heart valve for aortic regurgitation. Catheter Cardiovasc Interv 2018; 91: 1345-1351
18 Tung M, Wang X, Li F. et al. A versatile transapical device for aortic valvular disease: One-year outcomes of a multicenter study on the J-Valve system. J Cardiol 2018; 72: 377-384
19 Alharbi AA, Khan MZ, Osman M. et al. Transcatheter Aortic Valve Replacement vs Surgical Replacement in Patients With Pure Aortic Insufficiency. Mayo Clin Proc 2020; 95: 2655-2664